Epizyme, Inc. Business Finance Contracts & Agreements
24 Contracts & Agreements
- Credit Agreements (1 contract)
- Exchange Agreements (2)
- Guarantee Agreements (1)
- Investor Rights Agreements (1)
- Loan Agreements (2)
- Purchase Agreements (1)
- Stock Agreements (6)
- Underwriting Agreements (9)
- Warrant Agreements (1)
- Epizyme, Inc. 2013 Employee Stock Purchase Plan, as amended and effective September 1, 2022 (Filed With SEC on May 19, 2022)
- Underwriting Agreement, dated January 26, 2022, by and among the Company and Jefferies, LLC, as representative of the several Underwriters (Filed With SEC on January 27, 2022)
- Form of Restricted Stock Unit Agreement (Inducement Grant) (Filed With SEC on November 9, 2021)
- Form of Stock Option Agreement (Inducement Grant) (Filed With SEC on November 9, 2021)
- Amended and Restated Loan Agreement dated as of November 3, 2020 by and among the Registrant and BioPharma Credit Investments V (Master) LP, BPCR Limited Partnership and BioPharma... (Filed With SEC on February 23, 2021)
- Loan Agreement dated as of November 4, 2019 by and between the Registrant and BioPharma Credit Investments V (Master) LP and BioPharma Credit PLC (Filed With SEC on February 27, 2020)
- Warrant Agreement dated as of November 4, 2019 by and between the Registrant and RPI Finance Trust (Filed With SEC on February 27, 2020)
- Purchase Agreement dated as of November 4, 2019 by and between the Registrant and RPI Finance Trust (Filed With SEC on February 27, 2020)
- Guaranty and Security Agreement dated as of November 18, 2019 by and between the Registrant and BioPharma Credit PLC (Filed With SEC on February 27, 2020)
- Form of Series A Preferred Stock Certificate (Filed With SEC on March 7, 2019)
- Underwriting Agreement related to the Preferred Offering, dated March 6, 2019, by and among the Company and Jefferies, LLC, Citigroup Global Markets, Inc. and Cowen and Company,... (Filed With SEC on March 7, 2019)
- Underwriting Agreement related to the Common Offering, dated March 6, 2019, by and among the Company and Jefferies, LLC, Citigroup Global Markets, Inc. and Cowen and Company, as... (Filed With SEC on March 7, 2019)
- Underwriting Agreement, dated October 2, 2018, by and between the Company and Jefferies, LLC (Filed With SEC on October 3, 2018)
- Underwriting Agreement, dated September 13, 2017, by and among the Company and Morgan Stanley & Co. LLC, Jefferies, LLC and Leerink Partners LLC, as representatives of the several... (Filed With SEC on September 14, 2017)
- Epizyme, Inc. 13,333,334 Shares Common Stock ($0.0001 parvalue) Underwriting Agreement (Filed With SEC on January 7, 2016)
- Epizyme, Inc. 6,000,000 Shares Common Stock ($0.0001 parvalue) Underwriting Agreement (Filed With SEC on March 18, 2015)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisk denote omissions. Amendment to Collaboration and License Agreement (Filed With SEC on May 14, 2014)
- Epizyme, Inc. Shares Common Stock ($0.0001 par value) Underwriting Agreement (Filed With SEC on February 3, 2014)
- Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. FIRST AMENDMENT TO COMPANION DIAGNOSTICS... (Filed With SEC on January 27, 2014)
- Epizyme, Inc. Shares 1 Common Stock ($0.0001 par value) Underwriting Agreement (Filed With SEC on May 13, 2013)
- EPIZYME, INC. 2013 EMPLOYEE STOCK PURCHASE PLAN April 18, 2013 (Filed With SEC on April 26, 2013)
- EPIZYME, INC. Restricted Stock Agreement (Filed With SEC on April 26, 2013)
- Signature(s) Guaranteed: Medallion Guarantee Stamp (Filed With SEC on April 26, 2013)
- EPIZYME, INC. AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT April 2, 2012 TABLE OF CONTENTS (Filed With SEC on April 18, 2013)
